Ascletis Pharma Inc.
ASCLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $866 | $330 | $2,471 | $2,495 |
| Short-Term Investments | $1,082 | $1,969 | $2,078 | $5 |
| Receivables | $5 | $5 | $24 | $54 |
| Inventory | $4 | $6 | $21 | $56 |
| Other Curr. Assets | $14 | $18 | $18 | $21 |
| Total Curr. Assets | $1,971 | $2,333 | $2,545 | $2,632 |
| Property Plant & Equip (Net) | $57 | $68 | $73 | $78 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $12 | $26 | $17 | $78 |
| Long-Term Investments | -$997 | $63 | $11 | $37 |
| Tax Assets | $0 | $0 | -$11 | $0 |
| Other NC Assets | $1,082 | $1 | $23 | $6 |
| Total NC Assets | $154 | $158 | $112 | $198 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,125 | $2,491 | $2,657 | $2,830 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $3 | $1 |
| Short-Term Debt | $6 | $6 | $2 | $2 |
| Tax Payable | $4 | $2 | $2 | $4 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $143 | $133 | $101 | $84 |
| Total Curr. Liab. | $153 | $141 | $108 | $91 |
| LT Debt | $1 | $3 | $2 | $1 |
| Deferred Rev, NC | $4 | $6 | $7 | $9 |
| Deferred Tax Liab, NC | $0 | -$6 | -$7 | -$9 |
| Other NC Liab. | $0 | $6 | $7 | $9 |
| Total NC Liab. | $5 | $8 | $9 | $10 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $8 | $4 | $3 |
| Total Liabilities | $158 | $149 | $117 | $101 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$1,475 | -$1,174 | -$1,030 | -$715 |
| AOCI | $748 | $725 | $702 | $578 |
| Other Equity | $2,693 | $2,791 | $2,867 | $2,865 |
| Total Equity | $1,966 | $2,342 | $2,540 | $2,729 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,125 | $2,491 | $2,657 | $2,830 |
| Net Debt | -$858 | -$322 | -$2,467 | -$2,493 |